Target intelligence / Profile preview

Ribosomal protein L7 pseudogene 54 (RPL7P54)

Target
RPL7P54
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L7 pseudogene 54 (RPL7P54) is a processed pseudogene in the human genome that is related to the canonical ribosomal protein L7 gene (RPL7). Unlike the functional RPL7 gene, which codes for an essential protein component of the 60S large ribosomal subunit, RPL7P54 does not produce a functional protein product and is classified as a non-coding pseudogene[7][8]. Pseudogenes like RPL7P54 are considered genomic “fossils” created from gene duplication or retrotransposition events; they typically lack regulatory elements for gene expression, or contain disabling mutations that prevent functional protein synthesis[10][11]. RPL7P54 has no direct involvement as a molecular target for therapeutics, no established function in human biology, and is not associated with pathological processes or drug response[7][8]. There is no evidence or indication that this specific pseudogene is misspelled, mischaracterized, or otherwise incorrect or non-unique. Supporting details: RPL7P54 is specifically annotated as a pseudogene, meaning it does not encode a functional protein product[7][8]. As with most ribosomal protein pseudogenes, there are no described biological functions, drug interactions, or disease involvements[7][8][10][11]. Pseudogenes are not considered protein or receptor targets and do not belong to standard molecular target classes such as enzyme, receptor, transporter, etc.[7][8][10]. Summary: RPL7P54 is a non-functional processed pseudogene derived from the ribosomal protein L7 gene, does not encode a protein, has no biological function, and is not a therapeutic target[7][8][10][11].

Other names
RPL7_31_1789RPL7P54

Beyond the preview

Go deeper on Ribosomal protein L7 pseudogene 54 (RPL7P54).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7 pseudogene 54 (RPL7P54).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call